SCHEMBL5883635

SCHEMBL5883635

CCc1nc(C2(C)CCC(C)CC2)n2nc(-c3ccccc3)[nH]c(=O)c12

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 6/20 0.41
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
KHK P50053 4/20 0.36
PDE1A P54750 2/20 0.35
PDE1B Q01064 2/20 0.35
PDE1C Q14123 2/20 0.35
PDE3B Q13370 2/20 0.34
PDE3A Q14432 2/20 0.34
NPSR1 Q6W5P4 2/20 0.33
TSHR P16473 1/20 0.33
ALDH1A1 P00352 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
GAA P10253 1/20 0.32
POLB P06746 1/20 0.32
GUSB P08236 1/20 0.32
PDE2A O00408 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5884275 0.89 PDE5A (0.43) PDE5AKMT2AL3MBTL1KHKPDE1A
SCHEMBL5883597 0.86 PDE5A (0.38) PDE5AKMT2AMEN1KHKPDE1A
SCHEMBL5730009 0.85 KDM4E (0.34) PDE5AKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL5883819 0.81 PDE5A (0.46) PDE5AKMT2AMEN1KHKPDE1A
SCHEMBL5883663 0.81 PDE5A (0.46) PDE5AKMT2AMEN1KHKPDE1A
SCHEMBL5883648 0.80 PDE5A (0.42) PDE5AL3MBTL1KHKPDE1APDE1B
SCHEMBL5883506 0.79 PDE5A (0.38) PDE5AKHKPDE1APDE1BPDE1C
SCHEMBL5884415 0.79 PDE5A (0.45) PDE5AKMT2AKHKPDE1APDE1B
SCHEMBL5883977 0.78 KHK (0.34) PDE5AKMT2AMEN1KHKPDE1A
SCHEMBL5883995 0.78 PDE5A (0.49) PDE5AKMT2AL3MBTL1KHKPDE1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7087605-B2 5-Ethyl-imidazotriazinones BAYER AKTIENGESELLSCHAFT (DE) 2006-08-08 US disclosed
EP-1397363-B1 5-ETHYL-IMIDAZOTRIAZINONES BAYER HEALTHCARE AG (DE) 2005-05-11 EP disclosed
US-20040254187-A1 5-ethyl-imidazotriazinones BAYER HEALTHCARE AG (DE) 2004-12-16 US disclosed
EP-1397363-A1 5-ETHYL-IMIDAZOTRIAZINONES Bayer HealthCare AG (DE) 2004-03-17 EP disclosed
WO-2002098880-A1 5-ETHYL-IMIDAZOTRIAZINONES BAYER HEALTHCARE AG (DE) 2002-12-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040254187-A1 5-ethyl-imidazotriazinones EPX, TPMT, IL5 PDE5A 409/4885KMT2A 2767/4885MEN1 4060/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.